Hungary Reverse-Switches High-Dose Ibuprofen
OTC ibuprofen products marketed by Sanofi, Mylan and Zambon among those reverse-switched to Rx status by Hungary's drug regulator.

OTC ibuprofen products marketed by Sanofi, Mylan and Zambon among those reverse-switched to Rx status by Hungary's drug regulator.